Arterial endothelial function is impaired in treated depression

Objectives: To determine whether patients with treated depression but no other risk factors for coronary heart disease (CHD) have abnormal arterial endothelial function, an abnormality that is common to other acquired risk factors for CHD. Design: Case–control study. Setting: Secondary care departments of cardiology and psychiatry in a single centre and the surrounding community. Participants: Patients with treated depression and matched healthy controls, aged 18–55 years, without conventional acquired risk factors for CHD. These were recruited from local community mental health clinics, general practices, and patient support groups, and through posters placed in public areas of the hospital. Patients had major depression as defined in the American Psychiatric Association’s Diagnostic and statistical manual of mental disorders, fourth edition. Fifteen patients and 12 controls were recruited, and 12 patients and 10 controls completed the study. Outcomes: Brachial artery flow mediated dilatation and baroreflex sensitivity. Results: Arterial endothelial function measured by flow mediated dilatation was impaired in depression (mean (SEM) −0.7% (1.7%)) compared with controls (5.7% (0.9%), p = 0.005 by non-paired t test). Baroreflex sensitivity did not differ significantly between the groups. Conclusion: Arterial endothelial function is impaired in treated depression. This abnormality may contribute to the increased risk of CHD seen in depression.

[1]  B. Pollock,et al.  Paroxetine is a novel nitric oxide synthase inhibitor. , 1996, Psychopharmacology bulletin.

[2]  C. Nemeroff,et al.  Exaggerated platelet reactivity in major depression. , 1996, The American journal of psychiatry.

[3]  C. Jones,et al.  Endothelial control of arterial distensibility is impaired in chronic heart failure. , 1995, Circulation.

[4]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[5]  R. Hughson,et al.  Spontaneous cardiac baroreflex in humans. Comparison with drug-induced responses. , 1995, Hypertension.

[6]  C. Tangen,et al.  Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. , 2000, Circulation.

[7]  Octavio Gómez Dantés,et al.  The World Health Report 1999. Making a Difference , 1999 .

[8]  D. Ford,et al.  Depression is a risk factor for coronary artery disease in men: the precursors study. , 1998, Archives of internal medicine.

[9]  M. Moeschberger,et al.  Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. , 2000, Archives of internal medicine.

[10]  R. Crum,et al.  Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. , 1996, Circulation.

[11]  C. Nemeroff,et al.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.

[12]  A. Steptoe,et al.  Mental Stress Induces Transient Endothelial Dysfunction in Humans , 2000, Circulation.

[13]  E. H. Reynolds,et al.  Enhancement of recovery from psychiatric illness by methylfolate , 1990, The Lancet.

[14]  M. Schroll,et al.  Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. , 1996, Circulation.

[15]  M. Rubenfire,et al.  Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. , 2001, The American journal of cardiology.

[16]  N. Frasure-smith,et al.  Depression and 18-month prognosis after myocardial infarction. , 1995, Circulation.

[17]  C. Pope,et al.  Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. , 1994, American journal of public health.

[18]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[19]  B. Toone,et al.  Enhancement of recovery from psychiatric illness by methylfolate , 1992, British Journal of Psychiatry.

[20]  D. Webb,et al.  Cortisol inhibits cholinergic vasodilation in the human forearm. , 2000, American journal of hypertension.

[21]  R. Cannon,et al.  Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women. , 2000, Journal of the American College of Cardiology.

[22]  P. Grossman,et al.  Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. , 1999, American heart journal.

[23]  E. Eaker,et al.  Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. Adults , 1993, Epidemiology.

[24]  C. Tangen,et al.  Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans , 2000 .